Chemoinformaics analysis of Methanal, (5-methyl-3-isoxazolyl)amino-, oxime
| Molecular Weight | 141.13 | nRot | 2 |
| Heavy Atom Molecular Weight | 134.074 | nRig | 7 |
| Exact Molecular Weight | 141.054 | nRing | 1 |
| Solubility: LogS | -0.427 | nHRing | 1 |
| Solubility: LogP | 0.427 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 5 |
| nHA | 4 | APOL | 17.9216 |
| nHD | 2 | BPOL | 9.32845 |
| QED | 0.254 |
| Synth | 4.79 |
| Natural Product Likeliness | 0.067 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.124 |
| HIA | 0.28 |
| CACO-2 | -4.846 |
| MDCK | 0.0000115 |
| BBB | 0.638 |
| PPB | 0.36794 |
| VDSS | 0.752 |
| FU | 0.655298 |
| CYP1A2-inh | 0.367 |
| CYP1A2-sub | 0.617 |
| CYP2c19-inh | 0.151 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.793 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.731 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.158 |
| CL | 3.439 |
| T12 | 0.675 |
| hERG | 0.018 |
| Ames | 0.849 |
| ROA | 0.951 |
| SkinSen | 0.137 |
| Carcinogencity | 0.931 |
| EI | 0.96 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.896474 |